Cameron Turtle

Insider Reports History

Entity
Individual
Location
C/O Eidos Therapeutics, Inc., 101 Montgomery Street, Suite 2550, San Francisco, California
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cameron Turtle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spyre Therapeutics, Inc. Chief Executive Officer, Director Common Stock 747K $530K $0.71 Feb 15, 2024 Direct
Spyre Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 278K Feb 1, 2024 Direct
Spyre Therapeutics, Inc. Chief Executive Officer, Director Series A Preferred Stock 0 Nov 24, 2023 Direct

Insider Reports Filed by Cameron Turtle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRE Spyre Therapeutics, Inc. Feb 15, 2024 1 $3.93K 4 Feb 20, 2024 Chief Executive Officer, Director
SYRE Spyre Therapeutics, Inc. Feb 1, 2024 1 $0 4 Feb 2, 2024 Chief Executive Officer, Director
AGLE Spyre Therapeutics, Inc. Nov 22, 2023 3 $0 4 Nov 27, 2023 Chief Executive Officer, Director
AGLE Aeglea BioTherapeutics, Inc. Jun 22, 2023 0 $0 3 Jun 30, 2023 Chief Operating Officer